Insider Holders & Insider Ownership - ANI PHARMACEUTICALS INC (ANIP)

List of insiders holdings for ANI PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
MERIDIAN VENTURE PARTNERS II LP
Meridian Venture Partners II GP L.P.
Meridian Venture Partners II Co.
Brown Robert E. JR
10% Owner		2024-03-14 07:30:381,444,570
0		1,444,570Form 13D
SIMES STEPHEN M
Vice Chairman, President & CEO		2012-01-27 16:29:26800,000
202,267		1,002,267Form 4
EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
Cho Michael
10% Owner		2004-12-13 16:48:36709,819
0		709,819Form 13G
EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
10% Owner		2004-12-13 16:48:36709,819
0		709,819Form 13G
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		2024-07-19 17:30:1468,652
637,620		706,272Form 4
Lalwani Nikhil
PRESIDENT & CEO		2024-09-10 16:44:38373,859
0		373,859Form 4
MARSHBANKS TRACY
Director		2018-05-16 16:22:180
349,934		349,934Form 4
DONENBERG PHILIP B
Sr VP of Finance, CFO, Secy		2012-01-27 16:33:48329,322
0		329,322Form 4
RAYNOR DANIEL
Director		2018-03-19 16:54:290
289,003		289,003Form 4
Gassert Chad
SVP - CORP. DEV. & STRATEGY		2024-07-02 20:58:4349,679
193,226		242,905Form 4
PRZYBYL ARTHUR
President and CEO		2020-04-08 17:54:20190,309
0		190,309Form 4
Snabes Michael C
Sr. VP of Medical Affairs		2012-01-27 16:37:45165,000
0		165,000Form 4
CAREY STEPHEN P.
SVP & CFO		2024-06-06 07:34:13161,968
0		161,968Form 4
LEHMAN LEAH M
VP, Product Development		2005-08-25 15:16:38150,000
0		150,000Form 4/A
Marken James G.
SVP OPS & PROD DEV		2024-06-11 16:51:43117,829
0		117,829Form 4
SHERWIN STEPHEN A
Director		2012-03-30 17:27:49111,760
0		111,760Form 4
Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES		2021-03-29 20:11:2387,477
0		87,477Form 4
Mutz Christopher
HEAD OF RARE DISEASE		2024-05-22 18:14:2883,277
0		83,277Form 4
SULLIVAN LOUIS W
Director		2012-03-30 17:38:2282,898
0		82,898Form 4
Jamnick Robert J.
VP, Quality & Product Develop.		2014-05-27 16:38:1177,701
0		77,701Form 4
Gutwerg Ori
SVP, GENERICS		2024-06-06 18:21:4777,227
0		77,227Form 4
Walsh Patrick D
Director		2024-05-23 20:03:5374,712
0		74,712Form 4
HO ANGELA
Director		2004-03-22 15:48:2972,137
0		72,137Form 4
Arnold Charlotte C.
Vice President and CFO		2016-04-11 19:10:1662,298
0		62,298Form 4
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.		2024-10-15 17:57:4656,488
0		56,488Form 4
HAUGHEY THOMAS
Director		2024-05-23 19:45:4751,526
0		51,526Form 4
Davis Krista
SVP, CHIEF HR OFFICER		2024-09-13 16:23:1550,059
0		50,059Form 4
ROSENOW EDWARD C III
Director		2012-03-30 17:31:0145,540
0		45,540Form 4
KJAER PETER
Director		2010-04-02 16:26:5144,425
0		44,425Form 4
Thoma Jeanne
Director		2024-05-23 20:02:1840,609
0		40,609Form 4
NASH DAVID
Director		2023-05-24 16:31:1338,561
0		38,561Form 4
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS		2024-04-08 21:53:1234,036
0		34,036Form 3
Pera Antonio R
Director		2024-05-23 19:58:0331,037
0		31,037Form 4
POTTS JOHN T JR
Director		2012-03-30 17:34:4127,657
2,924		30,581Form 4
MANGANO ROSS J
Director		2014-09-16 16:40:5726,914
0		26,914Form 4
BELL STEVEN J
VP Research & Pre-Clinical Dev		2005-08-25 15:32:2725,000
0		25,000Form 4/A
TANNENBAUM RENEE P
Director		2024-05-23 19:59:4022,621
0		22,621Form 4
Penn Thomas A.
Director		2019-04-01 16:00:2116,710
0		16,710Form 4
HOLUBOW FRED
Director		2018-03-22 17:00:3516,144
0		16,144Form 4
Leonard Matthew J
Director		2024-05-23 19:54:1311,993
0		11,993Form 4
LANKAU PETER A
Director		2016-04-11 18:58:164,500
0		4,500Form 4
MORGENSTERN VICTOR A
Director		2007-06-14 16:53:130
0		0Form 4